Flashcards · Module 18
🧠 Brain Vessels, Sleep & Autonomics
4 of 4 cards published · read by the site’s author on 17 November 2026
Acute Stroke in Octogenarians: Is 85 too old for tPA or clot retrieval?
Needs clinical review
The Question Every Intern Asks:
An 87-year-old woman presents 2 hours after acute onset of right hemiplegia and expressive aphasia. Her family asks: "Is she too old for that clot-busting drug?"
The Evidence-Based Answer: ABSOLUTELY NOT! 🚀
What the Landmark Trials Proved:
The IST-3 Trial: randomised 3,035 patients treated up to 6 hours after stroke onset, 53% of them over 80. The effect of IV alteplase in patients over 80 was at least as large as in younger patients.
Alteplase raises the risk of fatal intracranial hemorrhage (2.7% vs 0.4% within 7 days), but the relative increase is similar irrespective of age.
Endovascular Thrombectomy (EVT): for large-vessel occlusion (ICA, MCA M1), the DAWN trial showed better function with EVT in patients last known well 6 to 24 h earlier, even in older adults (26.2% were aged ≥80).
The Golden Rule:
Chronological age alone should not rule out acute stroke thrombolysis or thrombectomy in appropriately selected older patients.
Sources checked (4) · 15 November 2026
- Effectiveness of intravenous recombinant plasminogen activator treatment in Chinese patients with acute ischaemic stroke aged over 80 years: a retrospective cohort study (2026)
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial (2012)
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials (2014)
- Age demonstrates limited predictive utility for functional outcomes after thrombectomy in patients aged ≥70 years with acute ischemic stroke: a single-center cohort study (2026)
Note: In the trial as a whole, 37% vs 35% were alive and independent at 6 months, which was not a significant difference; an ordinal analysis showed a significant shift towards better outcomes. (The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial (2012))
Note: An individual-patient meta-analysis found that alteplase given within four and a half hours improved the odds of a good outcome irrespective of age. (Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials (2014))
Cerebral Amyloid Angiopathy (CAA): The bleeding danger of blood thinners
Needs clinical review
The Clinical Dilemma:
An 81-year-old with Atrial Fibrillation needs anticoagulation. But an MRI of his brain reveals multiple tiny dark specks (microbleeds) scattered across the cortex. What is this, and is it safe to anticoagulate?
Pathology:
Cerebral Amyloid Angiopathy (CAA) is progressive deposition of amyloid-beta (Aβ) in the walls of small cortical and leptomeningeal vessels, which become fragile and can rupture.
Imaging Hallmarks on MRI (GRE / SWI sequences):
Multiple Cortical / Lobar Cerebral Microbleeds (CMBs)
Strict Sparing of Deep Brain Structures (no microbleeds in the basal ganglia, thalamus, or pons — which are typical of hypertensive microangiopathy!)
Cortical Superficial Siderosis (the MRI trace of old bleeding into the subarachnoid space over the brain's convexities)
Clinical Impact:
After hypertension, CAA is the second most common cause of spontaneous intracerebral hemorrhage (ICH) in people over 60, and its bleeds tend to recur.
Disseminated cortical superficial siderosis is considered a contraindication to anticoagulation, and a previous ICH makes the decision harder still.
Alternative for A-fib: Left Atrial Appendage Occlusion (LAAO / Watchman device) for patients who cannot take anticoagulants.
Sources checked (4) · 15 November 2026
- Not All Brain Bleeds Are Equal: An Etiology-First Framework for Stroke Prevention After Intracerebral Hemorrhage (2026)
- Clinical Management of Cerebral Amyloid Angiopathy. (2025)
- Cerebral amyloid angiopathy: a narrative review. (2025)
- Left atrial appendage occlusion: an alternative to anticoagulation in atrial fibrillation (2026)
Note: Without a previous ICH, anticoagulation (preferably apixaban) may be suggested for people with CAA who have atrial fibrillation. (Clinical Management of Cerebral Amyloid Angiopathy. (2025))
Note: LAAO is not risk-free: it carries procedural risks and generally needs short-term antithrombotic treatment. (Not All Brain Bleeds Are Equal: An Etiology-First Framework for Stroke Prevention After Intracerebral Hemorrhage (2026))
REM Sleep Behavior Disorder (RBD): Punching in your sleep warns of Parkinson's
Needs clinical review
The Story:
A 72-year-old man's wife complains that he violently kicks, punches, and screams during nightmares (e.g., dreaming he is fighting off wild animals). Last week, he rolled out of bed and bruised his forehead. What is this?
The Biology:
During normal REM sleep, the brainstem shuts off motor activity (REM atonia)—your brain dreams, but your body stays paralyzed. In REM Sleep Behavior Disorder (RBD), the pontine sublaterodorsal nucleus degenerates, causing loss of REM muscle atonia. Patients physically act out their dreams!
The Ominous Prognosis:
RBD is not just a sleep problem—it is a prodromal α-synucleinopathy!
More than 70% of patients with idiopathic RBD convert to an overt neurodegenerative disease within 12 years (about 6–7% a year; lifetime rates likely exceed 80%):
Parkinson Disease
Dementia with Lewy Bodies (DLB)
Multiple System Atrophy (MSA)
Management:
🛏️ Bedroom Safety First: Remove sharp objects and anything on the nightstand, pad furniture corners, put the mattress on the floor or use side rails, and protect the bed partner (pillows between them, or separate beds).
💊 Usually first: Melatonin (immediate-release, 3 mg at bedtime, titrated in 3 mg steps up to 15 mg): often preferred for its favorable side-effect profile.
💊 If not controlled: Clonazepam at bedtime, with caution: in older people it may increase falls and worsen cognitive impairment, and it can worsen sleep-disordered breathing.
Sources checked (3) · 15 November 2026
Note: Most patients initially respond to clonazepam 0.25–1.0 mg at bedtime. (Rapid Eye Movement Sleep Behavior Disorder as a Prodromal Manifestation of Alpha-Synucleinopathies (2026))
Sleep Apnea (OSA) & Nocturia: The midnight bathroom connection
Needs clinical review
The Clinical Puzzle:
A 75-year-old man wakes up 4 times every single night to urinate. His urologist prescribed Tamsulosin and Finasteride for BPH, but his nocturia didn't budge. Why should you order a sleep study?
The ANP Heart-Kidney Mechanism:
Airway Collapse: In Obstructive Sleep Apnea (OSA), the upper airway collapses during sleep.
Negative Chest Pressure: Breathing against the blocked airway creates negative intrathoracic pressure.
Atrial Stretch: This negative pressure over-expands the heart's atria.
Hormone Dump: The heart's stretch receptors think: "We are drowning in fluid!" and release Atrial Natriuretic Peptide (ANP).
Nocturnal Polyuria: ANP blocks the action of antidiuretic hormone (ADH), so the kidneys make more urine at night.
The Cure:
Place the patient on CPAP (Continuous Positive Airway Pressure).
CPAP splints the airway open → removes the negative chest pressure → less ANP at night → less nocturia.
Sources checked (2) · 15 November 2026
- Age- and Severity-Stratified Associations Among Polysomnographic Parameters, Lower Urinary Tract Symptoms, and Hormonal Markers in Men with Obstructive Sleep Apnea: A Cross-Sectional Study (2026)
- The Efficacy of Continuous Positive Airway Pressure Therapy on Nocturia in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis. (2015)
Note: In the meta-analysis, nocturia fell by 2.28 episodes a night on average and night-time urine volume by 183.12 mL. (The Efficacy of Continuous Positive Airway Pressure Therapy on Nocturia in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis. (2015))